- Home
- DNLI vs ATAT Comparison
DNLI vs ATAT Comparison
Compare DNLI & ATAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DNLI
- ATAT
- Stock Information
- Founded
- DNLI 2013
- ATAT 2013
- Country
- DNLI United States
- ATAT China
- Employees
- DNLI N/A
- ATAT N/A
- Industry
- DNLI Biotechnology: Biological Products (No Diagnostic Substances)
- ATAT Hotels/Resorts
- Sector
- DNLI Health Care
- ATAT Consumer Discretionary
- Exchange
- DNLI Nasdaq
- ATAT Nasdaq
- Market Cap
- DNLI 3.3B
- ATAT 3.7B
- IPO Year
- DNLI 2017
- ATAT 2022
- Fundamental
- Price
- DNLI $21.93
- ATAT $25.85
- Analyst Decision
- DNLI Strong Buy
- ATAT Strong Buy
- Analyst Count
- DNLI 13
- ATAT 2
- Target Price
- DNLI $38.91
- ATAT $23.69
- AVG Volume (30 Days)
- DNLI 1.1M
- ATAT 900.1K
- Earning Date
- DNLI 02-25-2025
- ATAT 11-19-2024
- Dividend Yield
- DNLI N/A
- ATAT 1.74%
- EPS Growth
- DNLI N/A
- ATAT 162.91
- EPS
- DNLI N/A
- ATAT 1.20
- Revenue
- DNLI N/A
- ATAT $950,764,843.00
- Revenue This Year
- DNLI N/A
- ATAT $55.87
- Revenue Next Year
- DNLI $651.24
- ATAT $25.40
- P/E Ratio
- DNLI N/A
- ATAT $21.59
- Revenue Growth
- DNLI 204.74
- ATAT 76.11
- 52 Week Low
- DNLI $14.56
- ATAT $15.22
- 52 Week High
- DNLI $33.33
- ATAT $29.90
- Technical
- Relative Strength Index (RSI)
- DNLI 51.28
- ATAT 46.80
- Support Level
- DNLI $18.52
- ATAT $24.92
- Resistance Level
- DNLI $22.37
- ATAT $26.04
- Average True Range (ATR)
- DNLI 1.31
- ATAT 0.94
- MACD
- DNLI 0.31
- ATAT -0.14
- Stochastic Oscillator
- DNLI 88.57
- ATAT 26.56
About DNLI Denali Therapeutics Inc.
Denali Therapeutics Inc is a biotechnology company that is engaged in developing and discovering therapeutics to defeat neurodegeneration disease. The company's development programs include the LRRK2 Inhibitor Program, which develops brain penetrant small molecule LRRK2 inhibitor product candidates for Parkinson's disease. Its key products include DNL201, DNL151, DNL747, ATV (Antibody Transport Vehicle), ETV (Enzyme Transport Vehicle), and others.
About ATAT Atour Lifestyle Holdings Limited
Atour Lifestyle Holdings Ltd is an upper-midscale hotel chain in China. The company derives revenues from franchise and management fees from its manachised hotels and sales of hotel supplies to manachised hotels, Operations of leased hotels, and sales of retail products. The company has one operating segment, which is the Atour Group.